Return of the morning sickness pill. Could Bendectin be coming back to market?
D000014:Abnormalities, Drug-Induced / Q000209:etiology; D000932:Antiemetics / Q000009:adverse effects / Q000627:therapeutic use; D004025:Dicyclomine; D004319:Doxylamine / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D004338:Drug Combinations; D005260:Female; D006801:Humans; D009325:Nausea / Q000188:drug therapy*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D011297:Prenatal Exposure Delayed Effects; D011736:Pyridoxine / Q000009:adverse effects / Q000627:therapeutic use*; D012306:Risk; D014481:United States; D014486:United States Food and Drug Administration; D014839:Vomiting / Q000188:drug therapy*
D000932:Antiemetics; D004338:Drug Combinations; C004454:dicyclomine, doxylamine, pyridoxine drug combination; D004025:Dicyclomine; D004319:Doxylamine; D011736:Pyridoxine